Articles & Issues
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © KIChE. All rights reserved.
All issues
막유화법을 이용한 Ca-alginate Microparticle 약물수송체의 제조와 약물방출특성
Drug Release Characterization and Proparation of Ca-Alginate Microparticle Drug Carrier using Membrane Emulsification Method
HWAHAK KONGHAK, October 1999, 37(5), 789-794(6), NONE
Download PDF
Abstract
최근까지 연구가 진행되어온 bead 형태를 가진 약물수송체는 크기가 큼으로 인해서 약제 투여 방식에 큰 한계를 가지고 있다. 이를 보완하기 위해 본 연구에서는 막유화법을 이용하여 반응기의 압력과 sodium alginate의 농도 변화에 따른 alginate microparticle 약물수송체를 제조하였다. 수송체내의 약물로는 양이온성 약물인 lidocaine.HCl, 비이온성 약물인 4-acetamidophenol, 음이온성 약물인 sodium salicylate를 사용하였으며, 이를 이온 강도 0.2의 pH 2, pH 7인 인산완충용액내에서 방출 실험을 실시하였다. 막유화법에서 alginate의 농도가 2 wt%일 때, 압력은 0.4*105 Pa일 때 가장 단분산경향을 보였는데, 이는 alginate의 카르복시기와 양이온성 약물의 이온성 결합 때문이다. pH 2와 pH 7의 완충용액에서의 방출 결과는 pH 2에서 많은 지연 효과가 있는 것으로 나타났는데, 이는 카르복시기와 완충용액내의 H+, Na+에 의한 해리도의 차이 때문이다. 이로서 bead 크기의 수백분의 일인 microparticle이 민감한 pH 반응성을 보이므로 그 자체를 약물수송체로 사용할 수 있을 뿐만 아니라 여러 제약 투여 방식에 유리하게 응용될 수 있음을 알 수 있다.
Conventional alginate bead has been limited to be used as a drug carrier because of its large size. To overcome the disadvantages of conventional large-size alginate drug beads, Ca-alginate microparticles were prepared using membrane emulsification method controlled with the sodium alginate concentration and the pressure of reactor. The optimal monodispersed microparticles were obtained with the concentration of 2 wt% alginate solution and the pressure of 0.4×105 Pa. The mean size of our prepared microparticles was about 4 ㎛. As the drug solutions, lidocaine·HCl(cationic), sodium salicylate(anionic) and 4-acetamidophenol(nonionic) were selected. These three different drugs were loaded in the drug carrier of prepared alginate microparticles. Drug releases were performed in the siduim phosphate buffers of pH 2 and pH 7 and ionic strength of 0.2. The release behavior with the variation of drug charge showed that of the cationic drug release was retarded more than anionic one due to the ionic interaction between carboxyl group of alginates and positive charge of cationic drug. From the comparison experiments of the buffers of pH 2 and pH 7, the release was much retarded at pH 2 buffer due to ionic repulsivw force or ionic attractive force between the carboxyl group and the hydroxy or sodium ion in the buffer. Conclusively, the usage of small-size pH sensitive microparticles as a drug carrier has a high potential for the application of drug delivery systems.
References
Okano T, "Intelligent Materials for Drug Delivery System,"; First International Symposium on Biomaterials and Drug Delivery Systems, Korean Research Institute of Chemical Technology, Taejon, Korea (1993)
Rosen HB, Kohn J, Leong K, Langer R, "Controlled Release System: Fabrication Technology," CRC Press, Boca Raton, 2 (1998)
Illum L, Davis SS, "Polymers in Controlled Drug Delivery," Wright, Bristol (1987)
Langer R, Peppas N, J. Macromol. Sci., 23, 61 (1983)
Haug A, Smidsrod O, Acta Chem. Scand., 9, 341 (1967)
Rak J, Chalaabala M, Heinrich J, Antoninova K, Farm. Obz., 53 (1984)
Badwan AA, Abumalooh A, Sallam E, Abuhalaf A, Jawan A, Drug Dev. Ind. Pharm., 11, 239 (1985)
Chowdary PK, Suresh KV, J. Pharm. Sci., 50 (1988)
Xi N, Tu Z, Pei Y, Lui D, Ma L, Yao Hsueh Hsueb Pao, 16 (1981)
Chun KH, Kwon IC, Kim YH, La SB, Sohn YT, Jeong SY, Arch. Pharm. Res., 19(2), 106 (1996)
Kitazawa H, Sato H, Adachi I, Masuko Y, Horikoshi I, Biol. Pharm. Bull., 20(3), 278 (1997)
Lim F, Moss RD, J. Pharm. Sci., 70 (1981)
Ma GH, Nagai M, Omi S, J. Appl. Polym. Sci., 66(7), 1325 (1997)
Omi S, Kaneko K, Nakayama A, Katami K, Taguchi T, Iso M, Nagai M, Ma GH, J. Appl. Polym. Sci., 65(13), 2655 (1997)
Katoh R, Asano Y, Furuya A, Sotoyama K, Tomita M, J. Membr. Sci., 113(1), 131 (1996)
Paavola A, Yliruusi J, Kajimoto Y, Kalso E, Wahlstrom T, Rosenberg P, Pharm. Res., 12(12), 1997 (1995)
Te Wierik GHP, Eissens AC, Bergsma J, Arends-Scholte AW, Bolhuis GK, Int. J. Pharm., 157, 181 (1997)
Park HY, Choi CR, Kim JH, Kim WS, Drug Delivery, 5(1), 13 (1998)
Park HY, Lee BC, Kim WS, HWAHAK KONGHAK, 35(2), 264 (1997)
Rosen HB, Kohn J, Leong K, Langer R, "Controlled Release System: Fabrication Technology," CRC Press, Boca Raton, 2 (1998)
Illum L, Davis SS, "Polymers in Controlled Drug Delivery," Wright, Bristol (1987)
Langer R, Peppas N, J. Macromol. Sci., 23, 61 (1983)
Haug A, Smidsrod O, Acta Chem. Scand., 9, 341 (1967)
Rak J, Chalaabala M, Heinrich J, Antoninova K, Farm. Obz., 53 (1984)
Badwan AA, Abumalooh A, Sallam E, Abuhalaf A, Jawan A, Drug Dev. Ind. Pharm., 11, 239 (1985)
Chowdary PK, Suresh KV, J. Pharm. Sci., 50 (1988)
Xi N, Tu Z, Pei Y, Lui D, Ma L, Yao Hsueh Hsueb Pao, 16 (1981)
Chun KH, Kwon IC, Kim YH, La SB, Sohn YT, Jeong SY, Arch. Pharm. Res., 19(2), 106 (1996)
Kitazawa H, Sato H, Adachi I, Masuko Y, Horikoshi I, Biol. Pharm. Bull., 20(3), 278 (1997)
Lim F, Moss RD, J. Pharm. Sci., 70 (1981)
Ma GH, Nagai M, Omi S, J. Appl. Polym. Sci., 66(7), 1325 (1997)
Omi S, Kaneko K, Nakayama A, Katami K, Taguchi T, Iso M, Nagai M, Ma GH, J. Appl. Polym. Sci., 65(13), 2655 (1997)
Katoh R, Asano Y, Furuya A, Sotoyama K, Tomita M, J. Membr. Sci., 113(1), 131 (1996)
Paavola A, Yliruusi J, Kajimoto Y, Kalso E, Wahlstrom T, Rosenberg P, Pharm. Res., 12(12), 1997 (1995)
Te Wierik GHP, Eissens AC, Bergsma J, Arends-Scholte AW, Bolhuis GK, Int. J. Pharm., 157, 181 (1997)
Park HY, Choi CR, Kim JH, Kim WS, Drug Delivery, 5(1), 13 (1998)
Park HY, Lee BC, Kim WS, HWAHAK KONGHAK, 35(2), 264 (1997)